241 related articles for article (PubMed ID: 17549370)
1. A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women.
Zubor P; Lasabova Z; Hatok J; Stanclova A; Danko J
Oncol Rep; 2007 Jul; 18(1):211-7. PubMed ID: 17549370
[TBL] [Abstract][Full Text] [Related]
2. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
3. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
[TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer.
Gervasini G; Carrillo JA; Garcia M; San Jose C; Cabanillas A; Benitez J
Cancer; 2006 Dec; 107(12):2850-7. PubMed ID: 17120199
[TBL] [Abstract][Full Text] [Related]
5. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
7. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
9. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor alpha gene and breast cancer risk (The Netherlands).
Onland-Moret NC; van Gils CH; Roest M; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Dec; 16(10):1195-202. PubMed ID: 16215870
[TBL] [Abstract][Full Text] [Related]
11. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
13. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
[TBL] [Abstract][Full Text] [Related]
14. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
Li H; Feng L; Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Li J; Xie Y
Acta Oncol; 2006; 45(5):597-601. PubMed ID: 16864175
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.
Kafka A; Sauer G; Jaeger C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Int J Oncol; 2003 May; 22(5):1117-21. PubMed ID: 12684679
[TBL] [Abstract][Full Text] [Related]
16. Her2 genotype and breast cancer progression in Korean women.
An HJ; Kim NK; Oh D; Kim SH; Park MJ; Jung MY; Kang H; Kim SG; Lee KP; Lee KS
Pathol Int; 2005 Feb; 55(2):48-52. PubMed ID: 15693849
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
[TBL] [Abstract][Full Text] [Related]
20. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
